STOCK TITAN

Insmed To Present at the Morgan Stanley 21st Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Insmed Incorporated to present at Morgan Stanley Global Healthcare Conference
Positive
  • Insmed Incorporated will present at the Morgan Stanley 21st Annual Global Healthcare Conference on September 11, 2023 at 2:55 p.m. ET
Negative
  • None.

BRIDGEWATER, N.J., Sept. 6, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present in a fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference in New York, on Monday, September 11, 2023 at 2:55 p.m. ET.

The fireside chat will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. The webcast will be archived for a period of 30 days following the conclusion of the live event.

About Insmed

Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company is progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is also advancing an early-stage research engine encompassing a wide range of technologies and modalities, including artificial intelligence-driven protein engineering, gene therapy, and protein manufacturing. Insmed is headquartered in Bridgewater, New Jersey, with additional offices and research locations throughout the United States, Europe, and Japan. Visit www.insmed.com to learn more.

Contact:

Investors:

Bryan Dunn
Executive Director, Investor Relations
Insmed
(646) 812-4030
bryan.dunn@insmed.com

Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com

Media:

Mandy Fahey
Executive Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com

(PRNewsfoto/Insmed Incorporated)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference-301918384.html

SOURCE Insmed Incorporated

FAQ

When and where will Insmed Incorporated present?

Insmed Incorporated will present at the Morgan Stanley 21st Annual Global Healthcare Conference in New York on September 11, 2023 at 2:55 p.m. ET.

How can I access the webcast of the presentation?

The webcast can be accessed by visiting the investor relations section of Insmed Incorporated's website at www.insmed.com.

How long will the webcast be available?

The webcast will be archived for a period of 30 days following the conclusion of the live event.

Insmed, Inc.

NASDAQ:INSM

INSM Rankings

INSM Latest News

INSM Stock Data

12.18B
171.85M
0.95%
111.88%
7.97%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BRIDGEWATER